Nilai Shock Index Sebagai Prediktor Mortalitas Terhadap Penderita Sepsis dan Sepsis Berat

(1)

(2)

LAMPIRAN 2.

LEMBAR PENJELASAN KEPADA CALON SUBJEK PENELITIAN

Selamat pagi/siang Bapak/Ibu, pada hari ini saya, dr.Riki Muljadi ,peserta

Pendidikan Pasca Sarjana Ilmu Penyakit Dalam / Magister Klinik FK USU Medan

akan melakukan penelitian yang berjudul ”

Nilai

Shock Index

Sebagai Prediktor

Mortalitas Terhadap Penderita Sepsis dan Sepsis Berat”.

Kepada Bapak/Ibu yang bersedia mengikuti penelitian ini nantinya akan diminta

mengisi surat persetujuan ikut dalam penelitian, mengikuti wawancara untuk

mencari adanya hal-hal yang dapat mengganggu penelitian, dilakukan pengukuran

tekanan darah (TD), suhu tubuh (Temprature Tubuh), frekwensi pernapasan

(Respiratory Rate/RR), denyut jantung (Heart Rate/HR) ,pemeriksaan laboratorium

berupa pemeriksaan darah sebanyak 30

( 2 sendok makan) yang akan diambil dari

lengan oleh ahlinya untuk menilai parameter darah rutin, fungsi hati, fungsi ginjal,

plasma prokalsitonin dan dilakukan kultur darah atau kultur spesimen dari dugaan

sumber infeksi guna mengetahui adanya jenis mikroorganisme yang terdapat dari

dalam darah ataupun dari spesimen sumber infeksi .

Manfaat penelitian ini adalah dengan dilakukannya pemeriksaan

Shock Index

terhadap penderita sepsis dan sepsis berat yang masuk di Instalasi Gawat Darurat,

maka kita dapat memprediksi tingkat mortalitas penderita sepsis dan sepsis berat

tersebut sehingga kita dapat mengambil sikap dalam hal penatalaksanaannya

selanjutnya.

Pada penelitian ini tidak menimbulkan efek samping apapun, hanya risiko yang

dapat terjadi dari penelitian ini adalah terjadinya memar pada tempat pengambilan

sampel darah setelah pengambilan darah dilakukan.

Setelah hasil akhir diperoleh, nantinya akan terlihat apakah terdapat hubungan

hubungan nilai

Shock Index-1

terhadap mortalitas, nilai

Shock Index-2

terhadap

mortalitas, nilai

Shock Index-3

terhadap mortalitas atau nilai rata rata

Shock

Index-1

,

Shock Index-2

dan

Shock Index-3

terhadap mortalitas Penderita sepsis dan sepsis

berat dari berbagai etiologi.Bila masih terdapat pertanyaan atau keluhan sewaktu

penelitian ini berjalan, maka Bapak/Ibu dapat menghubungi saya pada:

Nama

: dr. Riki Muljadi

Alamat

: Jl. Beo Indah I No.18 Medan - 20122

Telepon

: +6281221008100

Peneliti

(3)

LAMPIRAN 3.

SURAT PERSETUJUAN SETELAH PENJELASAN

(INFORMED CONCERN )

Saya yang bertanda tangan dibawah ini :

Nama

:...

Alamat

:...

Umur

:... Tahun

Jenis Kelamin : Laki-laki/ Perempuan.

No Telp/HP

:

Setelah mendapat penjelasan dari peneliti tentang kebaikan dan keburukan prosedur

penelitian ini, menyatakan bersedia

ikut serta dalam penelitian tentang ” Nilai

Shock

Index

Sebagai Prediktor Mortalitas Terhadap Penderita Sepsis dan Sepsis Berat”.

Apabila sewaktu-waktu saya mengundurkan diri dari penelitian ini, kepada saya

tidak dituntut apapun.

Demikianlah surat persetujuan bersedia ikut dalam penelitian ini saya buat, untuk

dapat digunakan seperlunya.

Medan, ...

Yang Memberi Pernyataan

(4)

LAMPIRAN 4

KERTAS KERJA PROFIL PESERTA PENELITIAN

I. IDENTITAS PRIBADI

Nama

:

Tempat/Tanggal Lahir :

Jenis Kelamin

: Laki-laki/Perempuan.

Pendidikan Terakhir :

Pekerjaan

:

Status

: Kawin/Belum Kawin. No Telp/Hp:...

Riwayat Penyakit

: DM / Hipertensi / Sakit jantung / Keganasan

Organ / Kelainan Darah /Gangguan Tiroid /

Pemakaian terapi steroid atau obat antiviral

Durasi/lama menderita :

Riwayat Penyakit dalam keluarga

:

2. PEMERIKSAAN FISIK

S-1

.

Tekanan Darah : ... mmHg.

Denyut Jantung (Heart Rate) : ... x/menit..

Frekwensi Pernafasan : ... x/menit. Temperatur : ...°C.

S-2

.

Tekanan Darah : ... mmHg. Denyut Jantung (Heart Rate) : ... x/menit..

Frekwensi Pernafasan : ... x/menit. Temperatur : ...°C..

S-3

.

Tekanan Darah : ... mmHg. Denyut Jantung (Heart Rate) : ... x/menit..

Frekwensi Pernafasan : ... x/menit. Temperatur : ...°C.

3. PEMERIKSAAN LABORATORIUM

Parameter

Nilai

Hb (gr/dl)

Leukosit (mm

)

Trombosit (mm

)

Fungsi Hati ( SGOT,SGPT )

Fungsi Ginjal (Ureum Creatinin)

Plasma Procalcitonin

(5)

LAMPIRAN 5. MASTER TABEL

Mortality ∑ SI

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27

1 MH 48 2 1 1 1 100 70 116 30 39.0 11.40 256 18000 42 0.90 23 28 6 4 1.20 1.16 0.73 0.26 0.72 2

2 BDM 44 1 1 1 1 100 60 118 32 38.4 12.30 312 16600 45.6 1.00 30 29 1 4 1.05 1.18 0.74 0.27 0.73 2

3 GS 51 1 1 5 1 100 70 108 30 38.2 10.20 358 10000 36.8 0.60 24 28 2 1 1.20 1.08 0.73 0.24 0.68 2

4 SB 57 1 1 1 1 100 70 118 30 39.2 11.20 199 14480 39.6 1.10 26 28 3 1 2.00 1.18 0.73 0.30 0.74 2

5 STM 35 2 1 11 1 100 80 110 28 38.6 10.80 107 15060 42 1.10 28 32 1 4 1.55 1.10 0.61 0.42 0.71 2

6 ESH 53 1 1 12 1 100 80 108 28 38.7 11.20 223 12470 60 1.27 30 36 1 5 1.34 1.08 0.52 0.42 0.67 2

7 BR 51 1 1 15 1 100 60 116 30 38.2 12.60 187 12600 38 0.78 41 38 1 1 1.02 1.16 0.78 0.18 0.71 2

8 HS 41 1 1 1 1 100 60 118 30 39.4 11.60 189 19800 52 1.12 33 29 1 1 1.76 1.18 0.72 0.14 0.68 2

9 DN 58 2 1 2 1 100 80 116 32 38.8 10.90 243 18200 24.7 0.88 27 30 5 7 1.59 1.16 0.52 0.10 0.59 2

10 MS 52 1 1 1 1 100 70 118 28 38.6 12.10 257 19900 46.6 1.10 24 30 1 5 1.05 1.18 0.56 0.32 0.69 2

11 SH 55 2 1 1 2 90 60 118 30 39.2 11.80 276 18400 41 0.80 26 24 2 1 1.13 1.31 0.77 0.12 0.73 2

12 RF 54 2 1 2 1 90 60 108 28 38.8 11.20 197 13000 40.2 1.09 21 25 6 7 1.24 1.20 0.56 0.34 0.70 2

13 HS 40 1 1 2 1 100 60 104 30 39.0 11.30 225 11000 39.9 1.03 28 30 6 7 1.91 1.04 0.71 0.42 0.72 2

14 KK 42 1 1 1 1 100 70 104 28 39.4 10.70 311 11770 28.8 0.60 22 26 2 1 1.25 1.04 0.56 0.34 0.65 2

15 MDN 55 1 1 5 1 90 70 106 28 38.6 10.90 215 15300 30.6 0.84 24 28 2 1 1.25 1.17 0.52 0.43 0.71 2

16 YR 42 2 1 11 1 100 80 110 20 38.4 11.20 187 16300 31.5 0.85 21 26 1 5 1.08 1.10 0.77 0.32 0.73 2

17 MES 55 1 1 2 1 100 80 116 28 38.2 12.40 255 18600 36.4 0.70 18 24 6 7 1.50 1.16 0.91 0.12 0.73 2

18 RM 43 2 1 12 1 100 60 116 30 38.4 11.40 244 13800 29.5 0.80 24 26 1 4 1.12 1.16 0.84 0.16 0.72 2

19 MN 39 1 1 1 1 90 60 108 28 38.6 11.30 276 14700 46.2 0.52 22 28 1 1 1.32 1.21 0.92 0.20 0.78 2

20 PH 49 1 1 2 1 100 60 106 30 39.0 12.20 366 12800 36.6 0.80 22 26 6 4 1.21 1.06 0.70 0.37 0.71 2

21 RS 53 1 1 1 1 90 60 110 28 38.8 11.10 421 12500 46.2 1.10 22 24 2 1 1.07 1.22 0.68 0.22 0.71 2

22 AST 42 1 1 1 1 100 70 116 28 38.6 13.20 298 12600 33.4 0.90 26 28 1 4 1.15 1.16 0.83 0.18 0.72 2

23 LTH 53 2 1 1 1 90 60 114 32 39.0 12.40 276 19200 26.4 0.57 28 30 2 1 1.25 1.26 0.71 0.20 0.72 2

24 MK 52 2 1 2 1 100 70 108 28 38.8 11.10 266 12000 36.4 0.90 22 24 7 4 1.26 1.21 0.71 0.19 0.70 2

25 MRH 43 2 1 11 2 90 60 110 32 39.6 10.80 287 13500 28.4 0.59 20 28 1 5 1.16 1.22 0.71 0.22 0.72 2

26 NRL 55 2 1 2 2 90 60 116 30 39.2 11.10 187 11800 48.2 1.10 20 26 7 4 1.17 1.21 0.66 0.21 0.69 2

27 MMH 50 2 1 1 1 90 60 110 28 38.0 10.80 287 15500 37.4 1.12 24 28 3 1 1.07 1.24 0.71 0.20 0.72 2

28 MTS 60 1 1 15 1 90 60 112 26 38.8 11.30 368 13530 36.4 0.60 22 26 1 5 0.90 1.24 0.66 0.20 0.70 2

29 SR 55 2 1 2 1 90 80 102 24 38.2 11.40 366 17970 34.2 0.80 24 28 6 7 1.21 1.13 0.82 0.15 0.70 2

30 SYM 44 2 1 3 1 100 70 110 28 38.4 11.20 322 11000 42.2 0.79 26 30 1 5 1.20 1.10 0.74 0.33 0.72 2

31 STN 47 2 1 5 3 90 50 100 32 38.8 10.20 187 12000 38.5 0.71 22 28 1 5 1.11 1.11 0.60 0.42 0.71 2

32 RHY 49 2 1 10 1 100 80 116 26 39.0 11.20 243 12460 42.6 1.10 20 26 2 1 1.05 1.22 0.61 0.27 0.70 2

33 RS 42 1 1 15 1 90 60 108 28 38.0 11.70 287 15800 42.4 0.69 24 28 1 5 1.53 1.20 0.66 0.25 0.70 2

34 FDK 60 1 1 1 1 100 50 112 26 38.4 13.60 311 12400 42.2 1.10 20 20 1 4 1.07 1.12 0.71 0.30 0.71 2

35 MYH 53 2 1 1 1 100 60 112 32 38.0 11.30 411 12700 33 1.10 24 26 2 1 1.53 1.12 0.73 0.30 0.72 2

36 RP 53 L 1 1 1 90 80 110 30 38.6 108.00 304 12340 28.4 0.80 22 28 1 1 1.25 1.22 0.64 0.22 0.69 2

37 AA 43 L 1 6 1 100 60 108 32 38.0 11.40 266 19600 36 0.60 24 30 1 1 1.25 1.08 0.75 0.28 0.70 2

38 AST 58 2 1 1 1 100 60 116 30 39.0 14.80 311 24700 40.8 1.10 28 30 1 5 1.57 1.16 0.81 0.18 0.72 2

39 SG 54 2 1 1 2 90 50 100 32 38.0 10.30 187 26700 32.4 1.10 22 28 2 1 1.34 1.11 0.68 0.35 0.71 2

40 MWH 33 2 1 14 1 100 70 118 30 38.2 12.50 366 17200 40 0.40 28 30 1 1 1.05 1.18 0.72 0.21 0.70 2

41 YLR 56 2 1 2 1 100 70 108 30 38.4 12.40 265 14500 39 1.20 22 28 6 7 1.21 1.08 0.77 0.24 0.70 2

42 RLD 40 2 1 12 1 100 60 114 32 39.0 10.80 244 13800 45 1.10 20 28 1 4 1.05 1.14 0.82 0.13 0.70 2

43 RHY 48 1 2 8 3 80 50 126 32 39.2 12.30 501 26600 71.4 2.80 29 31 1 4 8.83 1.57 1.89 2.41 1.96 1

44 AD 60 1 2 1 3 90 50 116 34 38.8 13.70 233 23200 69 2.90 28 31 1 4 28.60 1.40 1.99 2.45 1.95 1

45 TK 54 1 2 7 3 80 60 132 28 38.0 14.40 412 23602 82 3.64 30 31 2 1 7.42 1.57 2.17 2.28 2.01 1

46 ASL 51 1 2 1 3 80 50 130 28 38.6 11.80 335 20100 58 1.70 36 40 2 5 22.50 1.60 2.27 2.21 2.03 1

47 HS 40 1 2 6 4 60 40 126 30 36.8 11.30 222 43000 237 14.20 30 34 1 1 34.99 2.06 2.28 2.24 2.19 1

48 S T 56 2 2 2 4 90 60 132 30 36.2 14.80 211 33500 19 0.84 32 46 6 4 34.60 1.46 2.17 2.36 2.00 1

49 TH 56 2 2 7 4 60 40 122 30 37.5 10.60 189 45900 27.6 0.69 30 38 2 1 22.50 2.03 2.18 2.27 2.16 1

50 SP 44 2 2 3 3 80 50 130 32 36.8 12.80 321 27800 13 0.52 32 34 1 1 15.30 1.62 2.08 2.38 2.03 1

51 RS 58 2 2 1 4 70 50 126 34 38.8 11.60 433 38200 17.6 0.42 30 32 2 5 19.70 1.80 2.14 2.28 2.07 1

52 NM 41 2 2 8 3 80 50 126 30 36.8 13.20 256 20300 68.9 4.48 34 32 1 4 19.70 1.57 2.27 2.15 2.00 1

53 RN 56 1 2 1 2 90 50 132 30 36.5 11.20 287 19000 16.5 0.60 36 32 2 1 27.40 1.46 2.18 2.35 2.00 1

54 MS 52 2 2 6 3 80 50 124 32 36.7 10.20 367 17400 162 4.26 28 30 1 1 15.90 1.67 2.12 2.26 2.02 1

55 RN 51 2 2 1 2 90 60 132 32 36.0 14.90 354 24990 87.4 10.93 32 36 2 5 17.40 1.46 2.33 2.24 2.01 1

56 NTT 34 2 2 8 2 90 60 134 32 36.7 11.80 258 15300 6.8 0.52 30 34 1 4 54.20 1.48 2.21 2.32 2.00 1

57 EMA 38 2 2 7 3 80 50 124 30 36.2 11.40 198 18630 18.6 0.81 38 34 5 1 11.10 1.55 2.12 2.30 1.99 1

58 IS 55 2 2 1 4 80 40 128 34 37.3 10.80 328 28000 24 0.64 36 28 2 4 12.60 1.68 2.16 2.24 2.03 1

59 NH 43 2 2 3 2 80 50 130 36 37.0 13.40 256 14500 12 0.56 34 30 1 1 14.30 1.64 2.11 2.28 2.01 1

60 NN 39 2 2 6 2 90 50 136 32 38.0 11.10 286 12700 91 6.05 30 32 1 1 11.20 1.61 2.08 2.21 1.97 1

61 WP 51 1 2 8 4 70 50 128 32 39.2 10.50 210 42000 71.4 2.80 38 42 1 4 9.57 1.82 2.37 2.38 2.19 1

62 SL 60 1 2 1 4 70 50 124 34 39.8 12.10 207 23200 69 2.90 34 38 1 1 30.70 1.77 2.20 2.28 2.08 1

63 SH 54 2 2 7 2 90 60 132 30 38.0 10.30 150 13000 76 2.34 30 31 2 1 29.35 1.54 2.18 2.36 2.03 1

64 SP 52 2 2 1 3 90 50 138 36 39.0 11.00 174 17200 85.2 6.40 48 46 2 1 41.44 1.52 2.14 2.44 2.03 1

65 HH 47 1 2 1 4 70 50 128 30 38.6 11.40 127 20100 98 3.70 36 40 2 5 96.10 1.82 2.17 2.44 2.14 1

66 LN 32 2 2 6 4 80 50 124 32 40.2 11.40 195 24600 24.8 0.60 32 28 1 1 12.20 1.56 2.14 2.28 1.99 1

67 MTS 60 2 2 8 3 90 50 128 30 38.8 11.40 124 13500 43 1.20 31 30 1 4 18.47 1.42 2.22 2.26 1.97 1

68 BN 58 2 2 2 3 80 50 112 34 39.0 11.30 279 18400 59 2.70 30 34 6 4 3.30 1.44 2.06 2.21 1.90 1

69 RD 58 2 2 3 4 70 40 128 30 39.6 12.60 178 27500 68 3.40 34 32 1 1 42.30 1.82 2.16 2.24 2.07 1

70 NJA 60 2 2 1 4 70 50 120 30 39.2 13.60 211 39170 87.9 4.60 33 38 2 7 55.12 1.71 2.23 2.16 2.03 1

71 SS 41 1 2 8 4 80 50 128 34 41.0 10.60 187 32000 58.4 3.80 33 38 1 4 10.60 1.65 2.04 2.28 1.99 1

72 KRN 37 1 2 1 2 80 50 118 32 39.2 10.30 319 23300 52.9 2.08 28 30 2 1 7.30 1.47 2.16 2.28 1.97 1

73 WH 47 2 2 6 2 80 50 126 32 38.0 11.20 139 27400 87 3.20 34 36 1 1 9.30 1.57 1.97 2.31 1.95 1

74 JS 58 1 2 1 3 70 50 112 34 40.0 12.70 139 27600 88 2.10 30 36 2 1 15.30 1.62 2.10 2.28 2.00 1

75 RS 50 2 2 1 2 80 50 128 32 39.2 12.70 176 15600 78.5 2.17 28 32 3 4 31.20 1.68 2.08 2.26 2.01 1

76 RR 59 2 2 2 3 70 50 122 30 38.4 11.50 165 33700 64.2 2.30 33 36 6 4 23.00 1.74 2.18 2.35 2.09 1

77 NT 34 2 2 8 2 80 60 118 32 39.2 10.80 201 38000 75.1 2.10 24 30 1 1 47.20 1.68 2.18 2.27 2.04 1

78 LLI 49 2 2 1 3 70 50 128 36 39.4 12.00 188 27800 58.2 3.90 33 36 2 5 12.50 1.82 2.15 2.26 2.08 1

79 ELA 26 2 2 7 3 70 50 116 28 38.8 11.40 256 41000 75.4 4.20 32 36 3 1 31.50 1.65 2.11 2.24 2.00 1

80 MDN 38 2 2 6 2 80 50 128 30 38.6 10.70 302 22500 68.2 3.10 30 36 1 1 27.20 1.64 2.16 2.32 2.04 1

81 NH 43 2 2 3 3 80 40 126 32 39.2 10.40 233 20500 69.4 4.30 38 38 1 1 10.40 1.57 2.14 2.32 2.01 1

82 NN 39 2 2 6 4 70 40 122 34 39.4 13.80 211 39000 64.7 3.20 36 40 1 1 16.00 1.74 2.16 2.18 2.03 1

83 MS 52 2 2 1 4 80 50 128 36 38.6 14.20 276 36400 73.2 4.10 34 34 2 4 12.70 1.58 2.16 2.28 2.01 1

SENS S KD PCT

DIAGNOSIS

30 Hari

KS SGPT CR

UR SI-1 SI-2 SI-3

L/P UMUR NAMA N0.

LAMPIRAN MASTER TABEL HASIL PENELITIAN dr. Riki Muljadi

TANDA VITAL LABORATORIUM

SGOT HR

TDS

S/SS

(6)

Keterangan

I. Jenis Kelamin

1. Laki Laki (L)

2. Perempuan (P)

II.Sepsis / Syock Sepsis

1. Sepsis (S)

2. Syok Sepsis (SS)

III.Mortality 30 Hari

1. Meninggal Dunia

2. Hidup

IV.Diagnosa

1. Sepsis ec Community Acquired Pneumonia

2. Sepsis ec Ulcus Diabetikum

3. Sepsis ec Cholesistitis

4. Sepsis ec Cholangitis

5. Sepsis ec Hospital Acquired Pneumonia

6. Sepsis ec Combutio

7. Sepsis ec Lung Abcess

8. Sepsis ec Peritonitis

9. Sepsis ec Vulnus Punctum

10. Sepsis ec TB dengan Sekunder Infeksi

11. Sepsis ec Cystitis

12. Sepsis ec Appendicitis

13. Sepsis ec Pyelonefritis

14. Sepsis ec Placenta Rest

15. Sepsis ec Infeksi Saluran Kemih

V.Hasil Kultur

1. N

:Nihil

2. KP :Klebsiella Pneumoniae

3. SP :Streptococcus Pneumoniae

4. SA Staphyloccocus Aureus

5. EC :Escherichia Colli

6. PA :Pseudomonas aeruginosa

7. EA :Enterococcus faecali

VI. Tingkat Kesadaran

1. Compos mentis

2. Apatis

3. Somnolen

4. Coma

(7)

UJI STATISTIK

NPar Tests (+ Sepsis)

NPar Tests (Sepsis Berat)

One-Sample Kolmogorov-Smirnov Test

42 49.02 6.969 .144 .122 -.144 .936 .345

42 96.43 4.850 .412 .265 -.412 2.671 .000

42 65.71 8.874 .288 .288 -.188 1.865 .002

42 111.24 5.150 .180 .119 -.180 1.164 .133

42 29.10 2.428 .207 .140 -.207 1.341 .055

42 38.655 .4261 .106 .106 -.101 .687 .733

42 13.8405 14.91112 .459 .459 -.404 2.973 .000

42 270.07 67.853 .087 .078 -.087 .561 .911

42 15156.67 3631.219 .146 .146 -.104 .944 .335

42 38.512 7.1332 .093 .093 -.077 .601 .862

42 .8893 .22000 .200 .100 -.200 1.297 .069

42 24.38 4.179 .203 .203 -.123 1.316 .063

42 27.93 3.056 .181 .181 -.176 1.174 .127

42 1.2671 .24112 .226 .226 -.136 1.465 .027

42 .7062 .02767 .221 .166 -.221 1.432 .033

UMUR TDS TDD HR RR S Hb PLT WBC UR CR SGOT SGPT PCT Rerata SI

N Mean St d. Dev iation Normal Parametersa,b

Absolute Positiv e Negativ e Most Extreme Dif f erences

Kolmogorov -Smirnov Z Asy mp. Sig. (2-tailed)

Test distribution is Normal. a.

Calculated f rom data. b.

One-Sample Kolmogorov-Smirnov Test

42 48.36 9.017 .120 .098 -.120 .777 .582

42 78.33 8.239 .247 .206 -.247 1.600 .012

42 49.76 5.626 .350 .340 -.350 2.270 .000

42 125.95 5.868 .146 .102 -.146 .947 .331

42 31.86 2.182 .188 .188 -.145 1.220 .102

42 38.350 1.2196 .153 .112 -.153 .989 .282

42 11.9381 1.30271 .160 .160 -.091 1.038 .231

42 247.98 85.629 .143 .143 -.074 .928 .355

42 26356.95 9162.656 .119 .119 -.089 .773 .588

42 65.374 40.5806 .193 .193 -.142 1.253 .087

42 3.1107 2.65017 .192 .192 -.155 1.243 .091

42 32.52 3.946 .140 .140 -.118 .907 .384

42 34.71 4.313 .140 .140 -.090 .909 .381

42 23.9569 17.24400 .145 .145 -.143 .940 .339

42 2.0281 .06150 .202 .202 -.101 1.309 .065

UMUR TDS TDD HR RR S Hb PLT WBC UR CR SGOT SGPT PCT Rerata SI

N Mean St d. Dev iation Normal Parametersa,b

Absolute Positiv e Negativ e Most Extreme Dif f erences

Kolmogorov -Smirnov Z Asy mp. Sig. (2-tailed)

Test distribution is Normal. a.

Calculated f rom data. b.

(8)

T-Test

NPar Tests

Mann-Whitney Test

Ranks

42 61.89 2599.50

42 23.11 970.50

42 60.61 2545.50

42 24.39 1024.50

42 39.64 1665.00

42 45.36 1905.00

84 Sepsis + Sepsis Sepsis Berat Total + Sepsis Sepsis Berat Total + Sepsis Sepsis Berat Total TDS TDD Hb

N Mean Rank Sum of Ranks

Independent Samples Test

3.208 .077 .379 82 .706 .667 1.758 -2.831 4.165

.379 77.098 .706 .667 1.758 -2.835 4.168

5.837 .018 12.266 82 .000 18.095 1.475 15.161 21.030

12.266 66.364 .000 18.095 1.475 15.150 21.040

21.156 .000 9.840 82 .000 15.952 1.621 12.727 19.178

9.840 69.374 .000 15.952 1.621 12.718 19.186

.019 .892 -12.213 82 .000 -14.714 1.205 -17.111 -12.318

-12.213 80.643 .000 -14.714 1.205 -17.112 -12.317

.218 .642 -5.484 82 .000 -2.762 .504 -3.764 -1.760

-5.484 81.082 .000 -2.762 .504 -3.764 -1.760

35.200 .000 1.529 82 .130 .3048 .1993 -.0918 .7013

1.529 50.862 .133 .3048 .1993 -.0955 .7050

2.491 .118 .824 82 .413 1.90238 2.30960 -2.69215 6.49691

.824 41.626 .415 1.90238 2.30960 -2.75982 6.56458

Equal v ariances assumed Equal v ariances not assumed Equal v ariances assumed Equal v ariances not assumed Equal v ariances assumed Equal v ariances not assumed Equal v ariances assumed Equal v ariances not assumed Equal v ariances assumed Equal v ariances not assumed Equal v ariances assumed Equal v ariances not assumed Equal v ariances assumed Equal v ariances not assumed UMUR TDS TDD HR RR S Hb F Sig.

Lev ene's Test f or Equality of Variances

t df Sig. (2-tailed)

Mean Dif f erence

St d. Error

Dif f erence Lower Upper 95% Conf idence

Interv al of t he Dif f erence t-t est f or Equalit y of Means

(9)

T-Test

Test Statisticsa

67.500 121.500 762.000

970.500 1024.500 1665.000

-7.559 -7.126 -1.075

.000 .000 .282

Mann-Whitney U Wilcoxon W Z

Asy mp. Sig. (2-tailed)

TDS TDD Hb

Grouping Variable: Sepsis a.

Independent Samples Test

2.323 .131 1.311 82 .194 22.095 16.858 -11.441 55.631 1.311 77.929 .194 22.095 16.858 -11.467 55.658 29.977 .000 -7.365 82 .000 -11200.286 1520.808 -14225.7 -8174.914 -7.365 53.569 .000 -11200.286 1520.808 -14249.9 -8150.687 17.190 .000 -4.225 82 .000 -26.8619 6.3577 -39.5095 -14.2144 -4.225 43.531 .000 -26.8619 6.3577 -39.6790 -14.0448 23.017 .000 -5.414 82 .000 -2.22143 .41034 -3.03772 -1.40514 -5.414 41.565 .000 -2.22143 .41034 -3.04978 -1.39308 .082 .776 -9.182 82 .000 -8.143 .887 -9.907 -6.379 -9.182 81.733 .000 -8.143 .887 -9.907 -6.379 7.568 .007 -8.320 82 .000 -6.786 .816 -8.408 -5.163 Equal v ariances

assumed Equal v ariances not assumed Equal v ariances assumed Equal v ariances not assumed Equal v ariances assumed Equal v ariances not assumed Equal v ariances assumed Equal v ariances not assumed Equal v ariances assumed Equal v ariances not assumed Equal v ariances assumed Equal v ariances PLT WBC UR CR SGOT SGPT F Sig. Lev ene's Test f or Equality of Variances

t df Sig. (2-tailed) Mean Dif f erence

St d. Error

Dif f erence Lower Upper 95% Conf idence

Interv al of t he Dif f erence t-t est f or Equalit y of Means

Group Statistics

42 270.07 67.853 10.470

42 247.98 85.629 13.213

42 15156.67 3631.219 560.309

42 26356.95 9162.656 1413.829

42 38.512 7.1332 1.1007

42 65.374 40.5806 6.2617

42 .8893 .22000 .03395

42 3.1107 2.65017 .40893

42 24.38 4.179 .645

42 32.52 3.946 .609

42 27.93 3.056 .471

42 34.71 4.313 .665

Sepsis + Sepsis Sepsis Berat + Sepsis Sepsis Berat + Sepsis Sepsis Beart + Sepsis Sepsis Berat + Sepsis Sepsis Berat + Sepsis Sepsis PLT WBC UR CR SGOT SGPT

N Mean Std. Deviation

Std. Error Mean

(10)

Explore

Sepsis

Case Processing Summary

42 100.0% 0 .0% 42 100.0%

Sepsis + Sepsis Sepsis Berat UMUR

N Percent N Percent N Percent

Valid Missing Total

(11)

Descriptives

49.02 1.075

46.85 51.20 49.24 51.00 48.560 6.969 33 60 27 12

-.419 .365

-.783 .717

48.36 1.391

45.55 51.17 48.77 50.50 81.308 9.017 26 60 34 15

-.533 .365

-.628 .717

Mean

Lower Bound Upper Bound 95% Confidence

Interval for Mean 5% Trimmed Mean Median

Variance Std. Deviation Minimum Maximum Range

Interquartile Range Skewness

Kurtosis Mean

Lower Bound Upper Bound 95% Confidence

Interval for Mean 5% Trimmed Mean Median

Variance Std. Deviation Minimum Maximum Range

Interquartile Range Skewness

Kurtosis Sepsis

+ Sepsis

Sepsis Berat UMUR

Statistic Std. Error

Case Processing Summary

42 100.0% 0 .0% 42 100.0%

Sepsis + Sepsis Sepsis Berat TDS

N Percent N Percent N Percent

Valid Missing Total

(12)

Descriptives

96.43 .748

94.92 97.94 96.59 100.00 23.519 4.850 90 100 10 10

-.619 .365

-1.701 .717

78.33 1.271

75.77 80.90 78.68 80.00 67.886 8.239 60 90 30 10

-.224 .365

-.471 .717

Mean

Lower Bound Upper Bound 95% Confidence

Interval for Mean 5% Trimmed Mean Median

Variance Std. Deviation Minimum Maximum Range

Interquartile Range Skewness

Kurtosis Mean

Lower Bound Upper Bound 95% Confidence

Interval for Mean 5% Trimmed Mean Median

Variance Std. Deviation Minimum Maximum Range

Interquartile Range Skewness

Kurtosis Sepsis

+ Sepsis

Sepsis Berat TDS

Statistic Std. Error

Case Processing Summary

42 100.0% 0 .0% 42 100.0%

Sepsis + Sepsis Sepsis Berat TDD

N Percent N Percent N Percent

Valid Missing Total

(13)

Descriptives

65.71 1.369

62.95 68.48 65.79 60.00 78.746 8.874 50 80 30 10

.323 .365

-.768 .717

49.76 .868

48.01 51.52 49.74 50.00 31.649 5.626 40 60 20 0

-.010 .365

.418 .717

Mean

Lower Bound Upper Bound 95% Confidence

Interval for Mean 5% Trimmed Mean Median

Variance Std. Deviation Minimum Maximum Range

Interquartile Range Skewness

Kurtosis Mean

Lower Bound Upper Bound 95% Confidence

Interval for Mean 5% Trimmed Mean Median

Variance Std. Deviation Minimum Maximum Range

Interquartile Range Skewness

Kurtosis Sepsis

+ Sepsis

Sepsis Berat TDD

Statistic Std. Error

Case Processing Summary

42 100.0% 0 .0% 42 100.0%

Sepsis + Sepsis Sepsis Berat HR

N Percent N Percent N Percent

Valid Missing Total

(14)

Descriptives

111.24 .795

109.63 112.84 111.48 110.00 26.527 5.150 100 118 18 8

-.391 .365

-.650 .717

125.95 .905

124.12 127.78 126.11 127.00 34.437 5.868 112 138 26 8

-.535 .365

.311 .717

Mean

Lower Bound Upper Bound 95% Confidence

Interval for Mean 5% Trimmed Mean Median

Variance Std. Deviation Minimum Maximum Range

Interquartile Range Skewness

Kurtosis Mean

Lower Bound Upper Bound 95% Confidence

Interval for Mean 5% Trimmed Mean Median

Variance Std. Deviation Minimum Maximum Range

Interquartile Range Skewness

Kurtosis Sepsis

+ Sepsis

Sepsis Berat HR

Statistic Std. Error

Case Processing Summary

42 100.0% 0 .0% 42 100.0%

Sepsis + Sepsis Sepsis Berat RR

N Percent N Percent N Percent

Valid Missing Total

(15)

Descriptives

29.10 .375

28.34 29.85 29.32 30.00 5.893 2.428 20 32 12 2

-1.362 .365

3.648 .717

31.86 .337

31.18 32.54 31.84 32.00 4.760 2.182 28 36 8 4

.266 .365

-.533 .717

Mean

Lower Bound Upper Bound 95% Confidence

Interval for Mean 5% Trimmed Mean Median

Variance Std. Deviation Minimum Maximum Range

Interquartile Range Skewness

Kurtosis Mean

Lower Bound Upper Bound 95% Confidence

Interval for Mean 5% Trimmed Mean Median

Variance Std. Deviation Minimum Maximum Range

Interquartile Range Skewness

Kurtosis Sepsis

+ Sepsis

Sepsis Berat RR

Statistic Std. Error

Case Processing Summary

42 100.0% 0 .0% 42 100.0%

Sepsis + Sepsis Sepsis Berat S

N Percent N Percent N Percent

Valid Missing Total

(16)

Descriptives

38.655 .0657

38.522 38.788 38.644 38.600 .182 .4261 38.0 39.6 1.6 .7

.163 .365

-.714 .717

38.350 .1882

37.970 38.730 38.351 38.600 1.487 1.2196 36.0 41.0 5.0 2.0

-.307 .365

-.628 .717

Mean

Lower Bound Upper Bound 95% Confidence

Interval for Mean 5% Trimmed Mean Median

Variance Std. Deviation Minimum Maximum Range

Interquartile Range Skewness

Kurtosis Mean

Lower Bound Upper Bound 95% Confidence

Interval for Mean 5% Trimmed Mean Median

Variance Std. Deviation Minimum Maximum Range

Interquartile Range Skewness

Kurtosis Sepsis

+ Sepsis

Sepsis Berat S

(17)

Case Processing Summary

42 100.0% 0 .0% 42 100.0%

Sepsis + Sepsis Sepsis Berat Hb

N Percent N Percent N Percent

Valid Missing Total

Cases

Descriptives

13.8405 2.30084

9.1938 18.4871 11.5267 11.3000 222.341 14.91112 10.20 108.00 97.80 1.18

6.443 .365

41.666 .717

11.9381 .20101

11.5321 12.3440 11.8712 11.4500 1.697 1.30271 10.20 14.90 4.70 1.78

.759 .365

-.360 .717

Mean

Lower Bound Upper Bound 95% Confidence

Interval for Mean 5% Trimmed Mean Median

Variance Std. Deviation Minimum Maximum Range

Interquartile Range Skewness

Kurtosis Mean

Lower Bound Upper Bound 95% Confidence

Interval for Mean 5% Trimmed Mean Median

Variance Std. Deviation Minimum Maximum Range

Interquartile Range Skewness

Kurtosis Sepsis

+ Sepsis

Sepsis Berat Hb

(18)

Case Processing Summary

42 100.0% 0 .0% 42 100.0%

Sepsis + Sepsis Sepsis Berat PLT

N Percent N Percent N Percent

Valid Missing Total

Cases

Descriptives

270.07 10.470

248.93 291.22 268.82 266.00 4604.019 67.853 107 421 314 90

.170 .365

-.032 .717

247.98 13.213

221.29 274.66 242.72 227.50 7332.268 85.629 124 501 377 119

.907 .365

.727 .717

Mean

Lower Bound Upper Bound 95% Confidence

Interval for Mean 5% Trimmed Mean Median

Variance Std. Deviation Minimum Maximum Range

Interquartile Range Skewness

Kurtosis Mean

Lower Bound Upper Bound 95% Confidence

Interval for Mean 5% Trimmed Mean Median

Variance Std. Deviation Minimum Maximum Range

Interquartile Range Skewness

Kurtosis Sepsis

+ Sepsis

Sepsis Berat PLT

(19)

Case Processing Summary

42 100.0% 0 .0% 42 100.0%

Sepsis + Sepsis Sepsis Berat WBC

N Percent N Percent N Percent

Valid Missing Total

Cases

Descriptives

15156.67 560.309

14025.10 16288.23 14843.65 14140.00 1E+007 3631.219 10000 26700 16700 5510

1.242 .365

1.704 .717

26356.95 1413.829

23501.67 29212.24 26106.93 24795.00 8E+007 9162.656 12700 45900 33200 14643

.440 .365

-.796 .717

Mean

Lower Bound Upper Bound 95% Confidence

Interval for Mean 5% Trimmed Mean Median

Variance Std. Deviation Minimum Maximum Range

Interquartile Range Skewness

Kurtosis Mean

Lower Bound Upper Bound 95% Confidence

Interval for Mean 5% Trimmed Mean Median

Variance Std. Deviation Minimum Maximum Range

Interquartile Range Skewness

Kurtosis Sepsis

+ Sepsis

Sepsis Berat WBC

(20)

Case Processing Summary

42 100.0% 0 .0% 42 100.0%

Sepsis + Sepsis Sepsis Berat UR

N Percent N Percent N Percent

Valid Missing Total

Cases

Descriptives

38.512 1.1007

36.289 40.735 38.274 38.750 50.883 7.1332 24.7 60.0 35.3 9.0

.428 .365

.869 .717

65.374 6.2617

52.728 78.020 61.291 68.650 1646.786 40.5806 6.8 237.0 230.2 40.2

1.894 .365

7.318 .717

Mean

Lower Bound Upper Bound 95% Confidence

Interval for Mean 5% Trimmed Mean Median

Variance Std. Deviation Minimum Maximum Range

Interquartile Range Skewness

Kurtosis Mean

Lower Bound Upper Bound 95% Confidence

Interval for Mean 5% Trimmed Mean Median

Variance Std. Deviation Minimum Maximum Range

Interquartile Range Skewness

Kurtosis Sepsis

+ Sepsis

Sepsis Berat UR

(21)

Case Processing Summary

42 100.0% 0 .0% 42 100.0%

Sepsis + Sepsis Sepsis Berat CR

N Percent N Percent N Percent

Valid Missing Total

Cases

Descriptives

.8893 .03395

.8207 .9578 .8939 .8900 .048 .22000 .40 1.27 .87 .39

-.301 .365

-.983 .717

3.1107 .40893

2.2849 3.9366 2.7484 2.8500 7.023 2.65017 .42 14.20 13.78 2.84

2.400 .365

7.918 .717

Mean

Lower Bound Upper Bound 95% Confidence

Interval for Mean 5% Trimmed Mean Median

Variance Std. Deviation Minimum Maximum Range

Interquartile Range Skewness

Kurtosis Mean

Lower Bound Upper Bound 95% Confidence

Interval for Mean 5% Trimmed Mean Median

Variance Std. Deviation Minimum Maximum Range

Interquartile Range Skewness

Kurtosis Sepsis

+ Sepsis

Sepsis Berat CR

(22)

Case Processing Summary

42 100.0% 0 .0% 42 100.0%

Sepsis + Sepsis Sepsis Berat SGOT

N Percent N Percent N Percent

Valid Missing Total

Cases

Descriptives

24.38 .645

23.08 25.68 23.99 24.00 17.461 4.179 18 41 23 4

1.741 .365

4.992 .717

32.52 .609

31.29 33.75 32.31 32.00 15.573 3.946 24 48 24 4

1.346 .365

4.725 .717

Mean

Lower Bound Upper Bound 95% Confidence

Interval for Mean 5% Trimmed Mean Median

Variance Std. Deviation Minimum Maximum Range

Interquartile Range Skewness

Kurtosis Mean

Lower Bound Upper Bound 95% Confidence

Interval for Mean 5% Trimmed Mean Median

Variance Std. Deviation Minimum Maximum Range

Interquartile Range Skewness

Kurtosis Sepsis

+ Sepsis

Sepsis Berat SGOT

(23)

Case Processing Summary

42 100.0% 0 .0% 42 100.0%

Sepsis + Sepsis Sepsis Berat SGPT

N Percent N Percent N Percent

Valid Missing Total

Cases

Descriptives

27.93 .471

26.98 28.88 27.76 28.00 9.336 3.056 20 38 18 4

.777 .365

3.261 .717

34.71 .665

33.37 36.06 34.47 34.00 18.599 4.313 28 46 18 7

.780 .365

.508 .717

Mean

Lower Bound Upper Bound 95% Confidence

Interval for Mean 5% Trimmed Mean Median

Variance Std. Deviation Minimum Maximum Range

Interquartile Range Skewness

Kurtosis Mean

Lower Bound Upper Bound 95% Confidence

Interval for Mean 5% Trimmed Mean Median

Variance Std. Deviation Minimum Maximum Range

Interquartile Range Skewness

Kurtosis Sepsis

+ Sepsis

Sepsis Berat SGPT

(24)

Case Processing Summary

42 100.0% 0 .0% 42 100.0%

Sepsis + Sepsis Sepsis Berat PCT

N Percent N Percent N Percent

Valid Missing Total

Cases

Descriptives

1.2671 .03721

1.1920 1.3423 1.2463 1.2100 .058 .24112 .90 2.00 1.10 .26

1.375 .365

1.756 .717

23.9569 2.66081

18.5833 29.3305 22.1748 19.0850 297.356 17.24400 3.30 96.10 92.80 19.33

2.080 .365

6.384 .717

Mean

Lower Bound Upper Bound 95% Confidence

Interval for Mean 5% Trimmed Mean Median

Variance Std. Deviation Minimum Maximum Range

Interquartile Range Skewness

Kurtosis Mean

Lower Bound Upper Bound 95% Confidence

Interval for Mean 5% Trimmed Mean Median

Variance Std. Deviation Minimum Maximum Range

Interquartile Range Skewness

Kurtosis Sepsis

+ Sepsis

Sepsis Berat PCT

(25)

T-Test

NPar Tests

Mann-Whitney Test

Crosstabs

Group Statistics

42 1.2671 .24112 .03721

42 23.9569 17.24400 2.66081

42 .7062 .02767 .00427

42 2.0281 .06150 .00949

Sepsis + Sepsis Sepsis Berat + Sepsis Sepsis Berat PCT

Rerata SI

N Mean Std. Deviation

Std. Error Mean

Ranks

42 21.50 903.00

42 63.50 2667.00

42 21.50 903.00

42 63.50 2667.00

84 Sepsis

+ Sepsis Sepsis Berat Total + Sepsis Sepsis Berat Total PCT

Rerata SI

N Mean Rank Sum of Ranks

Independent Samples Test

47.448 .000 -8.527 82 .000 -22.68976 2.66107 -27.98347 -17.39605

-8.527 41.016 .000 -22.68976 2.66107 -28.06383 -17.31569

13.119 .001 -127.043 82 .000 -1.32190 .01041 -1.34260 -1.30121

-127.043 56.948 .000 -1.32190 .01041 -1.34274 -1.30107 Equal v ariances

assumed Equal v ariances not assumed Equal v ariances assumed Equal v ariances not assumed PCT

Rerata SI

F Sig.

Lev ene's Test f or Equality of Variances

t df Sig. (2-tailed)

Mean Dif f erence

St d. Error

Dif f erence Lower Upper 95% Conf idence

Interv al of t he Dif f erence t-t est f or Equalit y of Means

Test Statisticsa

.000 .000

Mann-Whitney U

(26)

**KS * Mortality**

Case Processing Summary

84 100.0% 0 .0% 84 100.0%

KS * Mortality KD * Mortality

N Percent N Percent N Percent

Valid Missing Total

Cases

Crosstab

21 21 42

21.0 21.0 42.0

50.0% 50.0% 100.0%

50.0% 50.0% 50.0%

25.0% 25.0% 50.0%

15 9 24

12.0 12.0 24.0

62.5% 37.5% 100.0%

35.7% 21.4% 28.6%

17.9% 10.7% 28.6%

2 2 4

2.0 2.0 4.0

50.0% 50.0% 100.0%

4.8% 4.8% 4.8%

2.4% 2.4% 4.8%

1 1 2

1.0 1.0 2.0

50.0% 50.0% 100.0%

2.4% 2.4% 2.4%

1.2% 1.2% 2.4%

3 7 10

5.0 5.0 10.0

30.0% 70.0% 100.0%

7.1% 16.7% 11.9%

3.6% 8.3% 11.9%

0 2 2

1.0 1.0 2.0

.0% 100.0% 100.0%

.0% 4.8% 2.4%

.0% 2.4% 2.4%

42 42 84

42.0 42.0 84.0

50.0% 50.0% 100.0%

100.0% 100.0% 100.0%

50.0% 50.0% 100.0%

Count

Expected Count % within KS % within Mortality % of Total Count

Expected Count % within KS % within Mortality % of Total

Count

Expected Count % within KS % within Mortality % of Total Count

Expected Count % within KS % within Mortality % of Total Klebsiella Pneumoniae Streptococcus Pneumoniae Escherichia Coll Pseudomonas aeruginosa Enterobacter aeruginosa KS Total Mati Hidup Mortality Total

Tidak Ada Pertumbuhan Bakteri

(27)

**KD * Mortality**

Chi-Square Tests

5.100a 5 .404

5.934 5 .313

2.473 1 .116

84 Pearson Chi-Square

Likelihood Ratio Linear-by -Linear Association N of Valid Cases

Value df

Asy mp. Sig. (2-sided)

6 cells (50.0%) hav e expected count less t han 5. The minimum expected count is 1.00.

Crosstab

23 17 40

20.0 20.0 40.0

57.5% 42.5% 100.0%

54.8% 40.5% 47.6%

27.4% 20.2% 47.6%

13 10 23

11.5 11.5 23.0

56.5% 43.5% 100.0%

31.0% 23.8% 27.4%

15.5% 11.9% 27.4%

5 9 14

7.0 7.0 14.0

35.7% 64.3% 100.0%

11.9% 21.4% 16.7%

6.0% 10.7% 16.7%

1 6 7

3.5 3.5 7.0

14.3% 85.7% 100.0%

2.4% 14.3% 8.3%

1.2% 7.1% 8.3%

42 42 84

42.0 42.0 84.0

50.0% 50.0% 100.0%

100.0% 100.0% 100.0%

50.0% 50.0% 100.0%

Count

Expected Count % within KD % within Mortality % of Total Count

Expected Count % within KD % within Mortality % of Total Tidak Ada Pertumbuhan

Bakteri

Staphyloccocus Aureus

Escherichia Coll

Enterobacter aeruginosa KD

Total

Mati Hidup

Mortality

(28)

ROC Curve

Chi-Square Tests

6.006a 3 .111

6.417 3 .093

3.854 1 .050

84 Pearson Chi-Square

Likelihood Ratio Linear-by -Linear Association N of Valid Cases

Value df

Asy mp. Sig. (2-sided)

2 cells (25.0%) hav e expected count less t han 5. The minimum expected count is 3.50.

Case Processing Summary

42 42 Mortalit y

Positiv ea

Negativ e

Valid N (listwise)

Larger v alues of the test result v ariable(s) indicate stronger ev idence f or a positiv e actual state.

The positiv e actual state is Mati. a.

1 - Specificity

1.0 0.8 0.6 0.4 0.2 0.0

Sens

itiv

ity

1.0 0.8 0.6 0.4

0.2 0.0

ROC Curve

Area Under the Curve

Test Result Variable(s): Rerata SI

1.000 .000 .000 1.000 1.000

Area St d. Errora

Asy mptotic

Sig.b Lower Bound Upper Bound

Asy mptotic 95% Conf idence Interv al

Under the nonparametric assumption a.

Null hy pothesis: true area = 0. 5 b.

(29)

Coordi nates of the Curve

Test Result Variable(s): Rerata SI

-.4100 1.000 1.000

.6200 1.000 .976

.6600 1.000 .952

.6750 1.000 .929

.6850 1.000 .881

.6950 1.000 .810

.7050 1.000 .571

.7150 1.000 .381

.7250 1.000 .143

.7350 1.000 .048

.7600 1.000 .024

1.3400 1.000 .000

1.9250 .976 .000

1.9550 .929 .000

1.9650 .905 .000

1.9800 .833 .000

1.9950 .762 .000

2.0050 .619 .000

2.0150 .476 .000

2.0250 .452 .000

2.0350 .286 .000

2.0550 .238 .000

2.0750 .190 .000

2.0850 .143 .000

2.0950 .119 .000

2.1200 .095 .000

2.1500 .071 .000

2.1750 .048 .000

3.1900 .000 .000

Positiv e if Greater Than

or Equal Toa Sensitiv ity 1 - Specif icity

The smallest cutof f v alue is the minimum

observ ed t est v alue minus 1, and the largest cutof f v alue is the maximum observ ed test v alue plus 1. All the other cutof f v alues are t he av erages of two consecutiv e ordered observ ed test v alues. a.

(30)

Crosstabs

Case Processing Summary

84 100.0% 0 .0% 84 100.0%

Rerata SI * Mort ality

N Percent N Percent N Percent

Valid Missing Total

Cases

Rerata SI * Mortality Crosstabul ation

42 0 42

21.0 21.0 42.0

100.0% .0% 100.0%

100.0% .0% 50.0%

50.0% .0% 50.0%

0 42 42

21.0 21.0 42.0

.0% 100.0% 100.0%

.0% 100.0% 50.0%

.0% 50.0% 50.0%

42 42 84

42.0 42.0 84.0

50.0% 50.0% 100.0%

100.0% 100.0% 100.0%

50.0% 50.0% 100.0%

Count

Expected Count % wit hin Rerata SI % wit hin Mortality % of Total Count

Expected Count % wit hin Rerata SI % wit hin Mortality % of Total >= 1,34 (Mati)

< 1,34 (Hidup) Rerata

Total

Mati Hidup

Mortalit y

Total

Chi-Square Tests

84.000b 1 .000

80.048 1 .000

116.449 1 .000

.000 .000

83.000 1 .000

84 Pearson Chi-Square

Continuity Correctiona

Likelihood Ratio Fisher's Exact Test Linear-by -Linear Association N of Valid Cases

Value df

Asy mp. Sig. (2-sided)

Exact Sig. (2-sided)

Exact Sig. (1-sided)

Computed only f or a 2x2 table a.

0 cells (.0%) hav e expected count less than 5. The minimum expected count is 21. 00.

(31)

NPar Tests (Meninggal)

Case Processing Summary

84 100.0% 0 .0% 84 100.0%

Sepsis * Mortalit y

N Percent N Percent N Percent

Valid Missing Total

Cases

Chi-Square Tests

84.000b 1 .000

80.048 1 .000

116.449 1 .000

.000 .000

83.000 1 .000

84 Pearson Chi-Square

Continuity Correctiona

Likelihood Ratio Fisher's Exact Test Linear-by -Linear Association N of Valid Cases

Value df

Asy mp. Sig. (2-sided)

Exact Sig. (2-sided)

Exact Sig. (1-sided)

Computed only f or a 2x2 table a.

0 cells (.0%) hav e expected count less than 5. The minimum expected count is 21. 00.

Sepsis * Mortality Crosstabulation

0 42 42

21.0 21.0 42.0

.0% 100.0% 100.0%

.0% 100.0% 50.0%

.0% 50.0% 50.0%

42 0 42

21.0 21.0 42.0

100.0% .0% 100.0%

100.0% .0% 50.0%

50.0% .0% 50.0%

42 42 84

42.0 42.0 84.0

50.0% 50.0% 100.0%

100.0% 100.0% 100.0%

50.0% 50.0% 100.0%

Count

Expected Count % within Sepsis % within Mortality % of Total Count

Expected Count % within Sepsis % within Mortality % of Total + Sepsis

Sepsis Berat Sepsis

Total

Mati Hidup

Mortality

(32)

NPar Tests (Hidup)

One-Sample Kolmogorov-Smirnov Test

42 48.36 9.017 .120 .098 -.120 .777 .582

42 78.33 8.239 .247 .206 -.247 1.600 .012

42 49.76 5.626 .350 .340 -.350 2.270 .000

42 125.95 5.868 .146 .102 -.146 .947 .331

42 31.86 2.182 .188 .188 -.145 1.220 .102

42 38.350 1.2196 .153 .112 -.153 .989 .282

42 11.9381 1.30271 .160 .160 -.091 1.038 .231

42 247.98 85.629 .143 .143 -.074 .928 .355

42 26356.95 9162.656 .119 .119 -.089 .773 .588

42 65.374 40.5806 .193 .193 -.142 1.253 .087

42 3.1107 2.65017 .192 .192 -.155 1.243 .091

42 32.52 3.946 .140 .140 -.118 .907 .384

42 34.71 4.313 .140 .140 -.090 .909 .381

42 23.9569 17.24400 .145 .145 -.143 .940 .339

42 2.0281 .06150 .202 .202 -.101 1.309 .065

UMUR TDS TDD HR RR S Hb PLT WBC UR CR SGOT SGPT PCT Rerata SI

N Mean St d. Dev iation Normal Parametersa,b

Absolute Positiv e Negativ e Most Extreme Dif f erences

Kolmogorov -Smirnov Z Asy mp. Sig. (2-tailed)

Test distribution is Normal. a.

Calculated f rom data. b.

One-Sample Kolmogorov-Smirnov Test

42 49.02 6.969 .144 .122 -.144 .936 .345

42 96.43 4.850 .412 .265 -.412 2.671 .000

42 65.71 8.874 .288 .288 -.188 1.865 .002

42 111.24 5.150 .180 .119 -.180 1.164 .133

42 29.10 2.428 .207 .140 -.207 1.341 .055

42 38.655 .4261 .106 .106 -.101 .687 .733

42 13.8405 14.91112 .459 .459 -.404 2.973 .000

42 270.07 67.853 .087 .078 -.087 .561 .911

42 15156.67 3631.219 .146 .146 -.104 .944 .335

42 38.512 7.1332 .093 .093 -.077 .601 .862

42 .8893 .22000 .200 .100 -.200 1.297 .069

42 24.38 4.179 .203 .203 -.123 1.316 .063

42 27.93 3.056 .181 .181 -.176 1.174 .127

42 1.2671 .24112 .226 .226 -.136 1.465 .027

42 .7062 .02767 .221 .166 -.221 1.432 .033

UMUR TDS TDD HR RR S Hb PLT WBC UR CR SGOT SGPT PCT Rerata SI

N Mean St d. Dev iation Normal Parametersa,b

Absolute Positiv e Negativ e Most Extreme Dif f erences

Kolmogorov -Smirnov Z Asy mp. Sig. (2-tailed)

Test distribution is Normal. a.

Calculated f rom data. b.

(33)

T-Test

Group Statistics

42 48.36 9.017 1.391

42 49.02 6.969 1.075

42 78.33 8.239 1.271

42 96.43 4.850 .748

42 49.76 5.626 .868

42 65.71 8.874 1.369

42 125.95 5.868 .905

42 111.24 5.150 .795

42 31.86 2.182 .337

42 29.10 2.428 .375

42 38.350 1.2196 .1882

42 38.655 .4261 .0657

42 11.9381 1.30271 .20101

42 13.8405 14.91112 2.30084

Mortality Mati Hidup Mati Hidup Mati Hidup Mati Hidup Mati Hidup Mati Hidup Mati Hidup UMUR

TDS TDD HR RR S Hb

N Mean St d. Dev iation

St d. Error Mean

(34)

.

NPar Tests

Mann-Whitney Test

Independent Samples Test

3.208 .077 -.379 82 .706 -.667 1.758 -4.165 2.831

-.379 77.098 .706 -.667 1.758 -4.168 2.835

5.837 .018 -12.266 82 .000 -18.095 1.475 -21.030 -15.161

-12.266 66.364 .000 -18.095 1.475 -21.040 -15.150

21.156 .000 -9.840 82 .000 -15.952 1.621 -19.178 -12.727

-9.840 69.374 .000 -15.952 1.621 -19.186 -12.718

.019 .892 12.213 82 .000 14.714 1.205 12.318 17.111

12.213 80.643 .000 14.714 1.205 12.317 17.112

.218 .642 5.484 82 .000 2.762 .504 1.760 3.764

5.484 81.082 .000 2.762 .504 1.760 3.764

35.200 .000 -1.529 82 .130 -.3048 .1993 -.7013 .0918

-1.529 50.862 .133 -.3048 .1993 -.7050 .0955

2.491 .118 -.824 82 .413 -1.90238 2.30960 -6.49691 2.69215

-.824 41.626 .415 -1.90238 2.30960 -6.56458 2.75982

Lev ene's Test f or Equality of Variances

t df Sig. (2-tailed)

Mean Dif f erence

St d. Error

Dif f erence Lower Upper 95% Conf idence

Interv al of t he Dif f erence t-t est f or Equalit y of Means

Ranks

42 23.11 970.50

42 61.89 2599.50

42 24.39 1024.50

42 60.61 2545.50

42 45.36 1905.00

42 39.64 1665.00

84 Mortality Mati Hidup Total Mati Hidup Total Mati Hidup Total TDS TDD Hb

(35)

T-Test

Test Statisticsa

67.500 121.500 762.000

970.500 1024.500 1665.000

-7.559 -7.126 -1.075

.000 .000 .282

Mann-Whitney U Wilcoxon W Z

Asy mp. Sig. (2-tailed)

TDS TDD Hb

Grouping Variable: Mortality a.

Group Statisti cs

42 247.98 85.629 13.213

42 270.07 67.853 10.470

42 26356.95 9162.656 1413.829

42 15156.67 3631.219 560.309

42 65.374 40.5806 6.2617

42 38.512 7.1332 1.1007

42 3.1107 2.65017 .40893

42 .8893 .22000 .03395

42 32.52 3.946 .609

42 24.38 4.179 .645

42 34.71 4.313 .665

42 27.93 3.056 .471

Mortality Mati Hidup Mati Hidup Mati Hidup Mati Hidup Mati Hidup Mati Hidup PLT

WBC UR CR SGOT SGPT

N Mean St d. Dev iation

St d. Error Mean

(36)

T-Test

Independent Samples Test

2.323 .131 -1.311 82 .194 -22.095 16.858 -55.631 11.441

-1.311 77.929 .194 -22.095 16.858 -55.658 11.467

29.977 .000 7.365 82 .000 11200.286 1520.808 8174.914 14225.658

7.365 53.569 .000 11200.286 1520.808 8150.687 14249.885

17.190 .000 4.225 82 .000 26.8619 6.3577 14.2144 39.5095

4.225 43.531 .000 26.8619 6.3577 14.0448 39.6790

23.017 .000 5.414 82 .000 2.22143 .41034 1.40514 3.03772

5.414 41.565 .000 2.22143 .41034 1.39308 3.04978

.082 .776 9.182 82 .000 8.143 .887 6.379 9.907

9.182 81.733 .000 8.143 .887 6.379 9.907

7.568 .007 8.320 82 .000 6.786 .816 5.163 8.408

8.320 73.877 .000 6.786 .816 5.161 8.411

Lev ene's Test f or Equality of Variances

t df Sig. (2-tailed)

Mean Dif f erence

St d. Error

Dif f erence Lower Upper

95% Conf idence Interv al of t he

Dif f erence t-t est f or Equalit y of Means

Group Statistics

42 23.9569 17.24400 2.66081

42 1.2671 .24112 .03721

42 2.0281 .06150 .00949

42 .7062 .02767 .00427

Mortalit y Mati Hidup Mati Hidup PCT Rerata SI

N Mean Std. Dev iat ion

Std. Error Mean

Independent Samples Test

47.448 .000 8.527 82 .000 22.68976 2.66107 17.39605 27.98347

8.527 41.016 .000 22.68976 2.66107 17.31569 28.06383

13.119 .001 127.043 82 .000 1.32190 .01041 1.30121 1.34260

127.043 56.948 .000 1.32190 .01041 1.30107 1.34274

Equal v ariances assumed Equal v ariances not assumed Equal v ariances assumed Equal v ariances not assumed PCT

Rerata SI

F Sig.

Lev ene's Test f or Equality of Variances

t df Sig. (2-tailed)

Mean Dif f erence

St d. Error

Dif f erence Lower Upper 95% Conf idence

Interv al of t he Dif f erence t-t est f or Equalit y of Means

(37)

NPar Tests

Mann-Whitney Test

**SI ke 1 * Mortality**

Ranks

42 63.50 2667.00

42 21.50 903.00

42 63.50 2667.00

42 21.50 903.00

84 Mortality

Mati Hidup Total Mati Hidup Total PCT

Rerata SI

N Mean Rank Sum of Ranks

Test Statisticsa

.000 .000

903.000 903.000

-7.893 -7.913

.000 .000

Mann-Whitney U Wilcoxon W Z

Asy mp. Sig. (2-tailed)

PCT Rerata SI

Grouping Variable: Mortalit y a.

Crosstab

42 0 42

100.0% .0% 100.0%

100.0% .0% 50.0%

50.0% .0% 50.0%

0 42 42

.0% 100.0% 100.0%

.0% 100.0% 50.0%

.0% 50.0% 50.0%

42 42 84

50.0% 50.0% 100.0%

100.0% 100.0% 100.0%

50.0% 50.0% 100.0%

Count

% within SI ke 1 % within Mortality % of Total Count

% within SI ke 1 % within Mortality % of Total >= 1,40 (Mati)

< 1,40 (Hidup) SI 1

Total

Mati Hidup

Mortality

(38)

**SI ke 2 * Mortality**

Chi-Square Tests

84.000b 1 .000

80.048 1 .000

116.449 1 .000

.000 .000

83.000 1 .000

84 Pearson Chi-Square

Continuity Correctiona

Likelihood Ratio Fisher's Exact Test Linear-by -Linear Association N of Valid Cases

Value df

Asy mp. Sig. (2-sided)

Exact Sig. (2-sided)

Exact Sig. (1-sided)

Computed only f or a 2x2 table a.

0 cells (.0%) hav e expected count less than 5. The minimum expected count is 21. 00.

Crosstab

42 0 42

100.0% .0% 100.0%

100.0% .0% 50.0%

50.0% .0% 50.0%

0 42 42

.0% 100.0% 100.0%

.0% 100.0% 50.0%

.0% 50.0% 50.0%

42 42 84

50.0% 50.0% 100.0%

100.0% 100.0% 100.0%

50.0% 50.0% 100.0%

Count

% within SI ke 2 % within Mortality % of Total Count

% within SI ke 2 % within Mortality % of Total >= 1,355 (Mati)

< 1,355 (Hidup) SI 2

Total

Mati Hidup

Mortality

(39)

Crosstabs

[DataSet1] E:\Data Riki SpPD 15-08-14.sav

**SI ke 3 * Mortality**

Chi-Square Tests

84.000b 1 .000

80.048 1 .000

116.449 1 .000

.000 .000

83.000 1 .000

84 Pearson Chi-Square

Continuity Correctiona

Likelihood Ratio Fisher's Exact Test Linear-by -Linear Association N of Valid Cases

Value df

Asy mp. Sig. (2-sided)

Exact Sig. (2-sided)

Exact Sig. (1-sided)

Computed only f or a 2x2 table a.

0 cells (.0%) hav e expected count less than 5. The minimum expected count is 21. 00.

Case Processing Summary

84 100.0% 0 .0% 84 100.0%

SI ke 3 * Mort ality

N Percent N Percent N Percent

Valid Missing Total

Cases

SI ke 3 * Mortality Crosstabulation

42 0 42

100.0% .0% 100.0%

100.0% .0% 50.0%

50.0% .0% 50.0%

0 42 42

.0% 100.0% 100.0%

.0% 100.0% 50.0%

.0% 50.0% 50.0%

42 42 84

50.0% 50.0% 100.0%

100.0% 100.0% 100.0%

50.0% 50.0% 100.0%

Count

% within SI ke 3 % within Mortality % of Total Count

% within SI ke 3 % within Mortality % of Total >= 1,29 (Mati)

< 1,29 (Hidup) SI 3

Total

Mati Hidup

Mortality

(40)

**Rerata SI * Mortality**

Chi-Square Tests

84.000b 1 .000

80.048 1 .000

116.449 1 .000

.000 .000

83.000 1 .000

84 Pearson Chi-Square

Continuity Correctiona

Likelihood Ratio Fisher's Exact Test Linear-by -Linear Association N of Valid Cases

Value df

Asy mp. Sig. (2-sided)

Exact Sig. (2-sided)

Exact Sig. (1-sided)

Computed only f or a 2x2 table a.

0 cells (.0%) hav e expected count less than 5. The minimum expected count is 21. 00.

Crosstab

42 0 42

100.0% .0% 100.0%

100.0% .0% 50.0%

50.0% .0% 50.0%

0 42 42

.0% 100.0% 100.0%

.0% 100.0% 50.0%

.0% 50.0% 50.0%

42 42 84

50.0% 50.0% 100.0%

100.0% 100.0% 100.0%

50.0% 50.0% 100.0%

Count

% wit hin Rerata SI % wit hin Mortality % of Total Count

% wit hin Rerata SI % wit hin Mortality % of Total >= 1,34 (Mati)

< 1,34 (Hidup) Rerata

Total

Mati Hidup

Mortalit y

(41)

Crosstabs

[DataSet1] D:\01 ABDUL JALIL AMRI ARMA 1958\05 DATA PPDS\SpPD

Riki\Data Riki SpPD 15-08-14.sav

Chi-Square Tests

84.000b 1 .000

80.048 1 .000

116.449 1 .000

.000 .000

83.000 1 .000

84 Pearson Chi-Square

Continuity Correctiona

Likelihood Ratio Fisher's Exact Test Linear-by -Linear Association N of Valid Cases

Value df

Asy mp. Sig. (2-sided)

Exact Sig. (2-sided)

Exact Sig. (1-sided)

Computed only f or a 2x2 table a.

0 cells (.0%) hav e expected count less than 5. The minimum expected count is 21. 00.

Case Processing Summary

84 100.0% 0 .0% 84 100.0%

SI ke 1 * Mortality SI ke 2 * Mortality SI ke 3 * Mortality Rerata SI * Mortality

N Percent N Percent N Percent

Valid Missing Total

(42)

**SI ke 1 * Mortality**

Chi-Square Tests

84.000b 1 .000

80.048 1 .000

116.449 1 .000

.000 .000

83.000 1 .000

84 Pearson Chi-Square

Continuity Correctiona

Likelihood Ratio Fisher's Exact Test Linear-by -Linear Association N of Valid Cases

Value df

Asy mp. Sig. (2-sided)

Exact Sig. (2-sided)

Exact Sig. (1-sided)

Computed only f or a 2x2 table a.

0 cells (.0%) hav e expected count less than 5. The minimum expected count is 21. 00.

Crosstab

42 0 42

100.0% .0% 100.0%

100.0% .0% 50.0%

50.0% .0% 50.0%

0 42 42

.0% 100.0% 100.0%

.0% 100.0% 50.0%

.0% 50.0% 50.0%

42 42 84

50.0% 50.0% 100.0%

100.0% 100.0% 100.0%

50.0% 50.0% 100.0%

Count

% within SI ke 1 % within Mortality % of Total Count

% within SI ke 1 % within Mortality % of Total >= 1,40 (Mati)

< 1,40 (Hidup) SI 1

Total

Mati Hidup

Mortality

(43)

**SI ke 2 * Mortality**

**SI ke 3 * Mortality**

Chi-Square Tests

84.000b 1 .000

80.048 1 .000

116.449 1 .000

.000 .000

83.000 1 .000

84 Pearson Chi-Square

Continuity Correctiona

Likelihood Ratio Fisher's Exact Test Linear-by -Linear Association N of Valid Cases

Value df

Asy mp. Sig. (2-sided)

Exact Sig. (2-sided)

Exact Sig. (1-sided)

Computed only f or a 2x2 table a.

0 cells (.0%) hav e expected count less than 5. The minimum expected count is 21. 00.

Crosstab

42 0 42

100.0% .0% 100.0%

100.0% .0% 50.0%

50.0% .0% 50.0%

0 42 42

.0% 100.0% 100.0%

.0% 100.0% 50.0%

.0% 50.0% 50.0%

42 42 84

50.0% 50.0% 100.0%

100.0% 100.0% 100.0%

50.0% 50.0% 100.0%

Count

% within SI ke 2 % within Mortality % of Total Count

% within SI ke 2 % within Mortality % of Total >= 1,355 (Mati)

< 1,355 (Hidup) SI 2

Total

Mati Hidup

Mortality

(44)

Pears Conti Likelih Fishe Linea Assoc N of a. b. Crosstab

42 0 42

100.0% .0% 100.0%

100.0% .0% 50.0%

50.0% .0% 50.0%

0 42 42

.0% 100.0% 100.0%

.0% 100.0% 50.0%

.0% 50.0% 50.0%

42 42 84

50.0% 50.0% 100.0%

100.0% 100.0% 100.0%

50.0% 50.0% 100.0%

Count

% within SI ke 2 % within Mortality % of Total Count

% within SI ke 2 % within Mortality % of Total >= 1,29 (Mati)

< 1,29 (Hidup) SI 3

Total

Mati Hidup

Mortality

Total

Coordi nates of the Curve

Test Result Variable(s): SI ke 1

.0400 1.000 1.000

1.0500 1.000 .952

1.0700 1.000 .929

1.0900 1.000 .833

1.1050 1.000 .762

1.1150 1.000 .714

1.1250 1.000 .667

1.1350 1.000 .643

1.1500 1.000 .619

1.1650 1.000 .452

1.1750 1.000 .429

1.1900 1.000 .310

1.2050 1.000 .262

1.2150 1.000 .190

1.2300 1.000 .095

1.2500 1.000 .048

1.2850 1.000 .024

1.3550 1.000 .000

1.4100 .976 .000

1.4300 .952 .000

1.4500 .929 .000

1.4650 .857 .000

1.4750 .833 .000

1.5000 .810 .000

1.5300 .786 .000

1.5450 .762 .000

1.5550 .738 .000

1.5650 .714 .000

1.5750 .595 .000

1.5900 .571 .000

1.6050 .548 .000

1.6150 .524 .000

1.6300 .476 .000

1.6450 .429 .000

1.6600 .381 .000

1.6750 .357 .000

1.6950 .286 .000

1.7250 .262 .000

1.7550 .190 .000

1.7850 .167 .000

1.8100 .143 .000

1.9250 .048 .000

Positiv e if Greater Than

(45)

Case Processing Summary

42 42

Mortalityb

Positiv ea

Negativ e

Valid N (listwise)

Larger v alues of the test result v ariable(s) indicat e stronger ev idence f or a positiv e actual stat e.

The positiv e actual state is Mati. a.

The test result v ariable(s): SI ke 1 has at least one tie between t he posit iv e actual state group and the negativ e act ual st ate group. b.

(46)

Area Under the Curve

Test Result Variable(s): SI ke 1

1.000 .000 .000 1.000 1.000

Area St d. Errora

Asy mptotic

Sig.b Lower Bound Upper Bound

Asy mptotic 95% Conf idence Interv al

Under the nonparametric assumption a.

Null hy pothesis: true area = 0. 5 b.

Case Processing Summary

42 42

Mortalityb

Positiv ea

Negativ e

Valid N (listwise)

Larger v alues of the test result v ariable(s) indicat e stronger ev idence f or a positiv e actual stat e.

The positiv e actual state is Mati. a.

The test result v ariable(s): SI ke 2 has at least one tie between t he posit iv e actual state group and the negativ e act ual st ate group. b.

Area Under the Curve

Test Result Variable(s): SI ke 2

1.000 .000 .000 1.000 1.000

Area St d. Errora

Asy mptotic

Sig.b Lower Bound Upper Bound

Asy mptotic 95% Conf idence Interv al

Under the nonparametric assumption a.

Null hy pothesis: true area = 0. 5 b.

(47)

Coordi nates of the Curve Test Result Variable(s): SI ke 2

-.4800 1.000 1.000

.5400 1.000 .929

.5800 1.000 .857

.6050 1.000 .833

.6250 1.000 .786

.6500 1.000 .762

.6700 1.000 .690

.6900 1.000 .643

.7050 1.000 .619

.7150 1.000 .476

.7250 1.000 .429

.7350 1.000 .333

.7450 1.000 .286

.7600 1.000 .262

.7750 1.000 .190

.7950 1.000 .167

.8150 1.000 .143

.8250 1.000 .095

.8350 1.000 .071

.8750 1.000 .048

.9150 1.000 .024

1.4050 1.000 .000

1.9300 .976 .000

1.9800 .952 .000

2.0150 .929 .000

2.0500 .905 .000

2.0700 .881 .000

2.0900 .810 .000

2.1050 .786 .000

2.1150 .738 .000

2.1300 .690 .000

2.1450 .595 .000

2.1550 .571 .000

2.1650 .429 .000

2.1750 .357 .000

2.1900 .238 .000

2.2050 .214 .000

2.2150 .190 .000

2.2250 .167 .000

2.2450 .143 .000

2.2650 .119 .000

2.2750 .071 .000

2.3050 .048 .000

2.3500 .024 .000

3.3700 .000 .000

Positiv e if Greater Than

or Equal Toa Sensitiv ity 1 - Specif icity

The smallest cutof f v alue is the minimum observ ed t est v alue minus 1, and the largest cutof f v alue is the maximum observ ed test v alue plus 1. All the other cutof f v alues are t he av erages of two consecutiv e ordered observ ed test v alues. a.

(1)

VII. Journal Reading di Departemen Ilmu Penyakit Dalam 1. Hypoglicaemia In Severe Malaria,Clinical Assosiacions and

Relationship To Quinin Dose

2. Diagnostic Value Of Clinical Parameter in The Prediction of Aspirin Exacerbatie Respiratory

3. Family History of Liver Cancer and Hepato Carcinoma

4. Soft Drink and Juice Consumtion and Risk Factor of Pancreatic Cancer

5. Changes In The Thyroid Function of Grave Disease Patient 6. LMWH VS UFH In Patient With Acute NSTEMI

7. Asymptomatic Hyperglicaemia In Long Term Psychiatry Patient of Diabetes Mielitus

8. Iron Restricted Erytropoesis in Anemia Patient with Giant Cell Arthritis.

9. Mobility Stress Test Approach To Predicting Fraility,Disability and Mortality.

10. Factor Associated With 24 Hours Urinary Volume

VIII. Tulisan Ilmiah di Departemen Ilmu Penyakit Dalam 1. Nelson’s Syndrome

2. Faktor V Leiden 3. Post Power Syndrome 4. Cardiac Tamponade

IX. Publikasi Ilmiah di Departemen Ilmu Penyakit Dalam

1. Riki Muljadi, Endang Sembiring, Saut Marpaung, Franciscus Ginting, Tambar Kembaren, Armon Rahimi, Yosia Ginting NOSOCOMIAL INFECTIONS DUE TO INFUSION INSTALLATION. National Congresss, Perhimpunan Peneliti Penyakit Tropik Indonesia (PETRI) XVII,Emerging and Re-emerging Infectious Diseases: A Local and Global Threat, Patra Semarang Convention Hotel, 08-10th July 2011. 2. Riki Muljadi , M. Darma Muda Setia,Zuhrial Zubir, E.N Keliat,

(2)

Hotel Grand Aston, 12 - 15 Desember 2012.

X. PARTISIPASI DALAM KEGIATAN ILMIAH

1. Peserta Simposium “Early Insulin inisiation, how, when and what insulin according to daily practice need. Medan, 21 November 2009. 2. Peserta Simposium “Update On Wound Management”, Hotel JW

Mariott, Medan, 16 Oktober 2010.

3. Peserta Simposium “Update on Diabetes Management and Medical

Nutrition Therapy”, Hotel Grand Aston, 17 April 2010.

4. Peserta Workshop Perdarahan Saluran Cerna, Gastroentero-Hepatologi Update VIII 2010, Convention Hall Hotel Danau Toba Medan, 21 Oktober 2010.

5. Peserta Workshop Ascites, Gastroentero-Hepatologi Update VIII 2010, Convention Hall Hotel Danau Toba Medan, 21 Oktober 2010. 6. Peserta Seminar “Current Management in Internal Medicine” dan

Workshop Ultrasonography. Pertemuan Ilmiah Tahunan (PIT) XI 2010. Departemen Ilmu Penyakit Dalam. Medan, 01 – 03 April 2010. 7. Peserta Simposium “ New Advance in Treatment of Type 2 Diabetes”.

Medan, 18 Juli 2010.

8. Panitia Simposium “Clinical Rheumatology in Daily Practice”,

Rheumatology Update 2010. Medan, 31 Juli - 01Agustus 2010.

9. Peserta Simposium “Clinical Rheumatology in Daily Practice”,

Rheumatology Update 2010. Medan, 31 Juli - 01Agustus 2010. 10. Peserta Simposium “Hiperglicemia of patients with diabetes mellitus

in clinical practice”. Medan, 28 November 2010.

11. Peserta Peserta National Congresss, Perhimpunan Peneliti Penyakit Tropik

Indonesia (PETRI) XVII,Emerging and Re-emerging Infectious Diseases: A Local and Global Threat, Patra Semarang Convention Hotel, 08-10th July 2011.

(3)

12. Peserta Pelatihan Program Pengembangan Pendidikan Keprofesian Berkelanjutan FK USU Workshop Tatalaksana Demam Berdarah Dengue. Ruang Seminar FK USU, 15 Januari 2011.

13. Peserta Seminar Hepatitis Update. Ruang Seminar FK USU, 23 Februari 2011.

14. Peserta Pelatihan Program Pengembangan Pendidikan Keprofesian Berkelanjutan Ultrasonografi Tahap Pertama bagi Spesialis dan PPDS Penyakit Dalam. Departemen Penyakit Dalam FK USU dan PUSKI. Medan, 21-24 Maret 2011.

15. Panitia Simposium dan Workshop PIT XII 2011 Penyakit Dalam, Pertemuan Ilmiah Nasional PERPARI. Medan 28-30 April 2011. 16. Peserta Simposium PIT XII 2011 Penyakit Dalam, Pertemuan Ilmiah

Nasional PERPARI. Medan 28-30 April 2011.

17. Peserta Workshop “Nutritional Problems in Critical Ill Patients”.

PIT XII 2011 Penyakit Dalam, Pertemuan Ilmiah Nasional PERPARI. Medan 28-30 April 2011.

18. Peserta Workshop “Insulin In Daily Practice”. PIT XII 2011

Penyakit Dalam, Pertemuan Ilmiah Nasional PERPARI. Medan 28-30 April 2011.

19. Peserta Simposium “ The Future Management Cardiovascular Management”. The 6th

NTCM. Medan 23-25 Juni 2011.

20. Peserta Workshop “Management Acute Coronary Syndrome”. The 6th NTCM. Medan 23-25 Juni 2011.

21. Peserta Workshop “Management Acute and Chronic Heart Failure”. The 6th NTCM. Medan 23-25 Juni 2011.

22. Peserta Simposium “The Future Management Cardiovascular Management”. The 6th New Trend in Cardiovascular Management (NTCM). Departemen Kardiologi dan Vaskular Medicine. Medan, 23 – 25 Juni 2011.

23. Peserta Simposium “Achieving Ambitious Glycaemic Target in Diabetes : Stepwise Treatment From Sulfonilurea to Insulin Initiation

(4)

Juli 2011.

24. Peserta Workshop Penyuntikan Intraartikuler. Rheumatology Update 2011. Medan, 07 Juli 2011.

25. Panitia Rheumatologi Update Departemen Penyakit Dalam FK USU, Medan 9-10 juli 2011.

26. Peserta Seminar Sehari Lymphoma Update : Deteksi Dini dan Penatalaksanaan. Medan, 16 Juli 2011.

27. Peserta Seminar Update. Gedung Abdul Hakim, HUT FK USU ke 59, Sabtu, 30 Juli 2011.

28. Peserta Seminar Update. HUT FK USU Ke-59. Medan, 30 Juli 2011. 29. Peserta Workshop “Course Cum Workshop on Hypertension for

Clinical Practice”. Medan 10 September 2011.

30. Peserta Roadshow “Medskup Cardio-Workshop Gastroentero-Hepatology & Infection-Immunology”, Grand Aston City Hall Medan, 8 Oktober 2011.

31. Peserta Workshop Ascites Gastroentero-hepatologi Update IX 2011, PPHI-PGI-PEGI- Divisi Gastroentero-Hepatologi Departemen Ilmu Penyakit Dalam FK USU, Medan, 03-05 November 2011.

32. Peserta Workshop Hepatitis B dan C Gastroentero-hepatologi Update IX 2011, PPHI-PGI-PEGI- Divisi Gastroentero-Hepatologi Departemen Ilmu Penyakit Dalam FK USU, Medan, 03-05 November 2011

33. Peserta Workshop Ensefalopati Hepatik Gastroentero-hepatologi Update IX 2011, PPHI-PGI-PEGI- Divisi Gastroentero-Hepatologi Departemen Ilmu Penyakit Dalam FK USU, Medan, 03-05 November 2011.

34. Peserta Simposium Perdarahan Saluran Cerna, Gastroentero-Hepatologi Update IX 2010, Convention Hall Hotel Danau Toba Medan, 4-5 November 2011.

(5)

35. Panitia Pelatihan Program Pengembangan Pendidikan Keprofesian Berkelanjutan Ultrasonografi Tahap kedua bagi Spesialis dan PPDS Penyakit Dalam. Departemen Penyakit Dalam FK USU dan PUSKI. Medan, 8-10 November 2011.

36. Peserta Mini Symposium “Patophysiology and Recent Management of Chronic Constipation and Acute Diarrhea”. Medan, 13 November

2011.

37. Peserta Simposium “ Pathogenesis, Prevention and Management

Diabetic Vascular Complications”. Medan, 20 Nopember 2011.

38. Peserta Round Table Discussion “Modifikasi Penggunaan Ekstrak Bahan Alami untuk Pengobatan Tukak Lambung”. Hotel JW Marriot Medan, 3 Desember 2011.

39. Peserta Simposium dan Workshop Head CT Scan “Clinical and Radiology Approach of Stroke and Head Injury”. Gedung Abdul Hakim FK USU Medan, 17 Desember 2011.

40. Peserta Simposium dan “The Management of Stroke Prevention: Current Updates”. IDI Wilayah Medan, 5 Februari 2012.

41. Peserta Simposium “Cancer Pain Management”. Hotel Grand Aston Medan, 10 Maret 2012.

42. Panitia Simposium dan Workshop “Diabetes Update for Excellent”. Hotel JW Marriot Medan, 17 Maret 2012.

43. Peserta Simposium “Diabetes Update for Excellent”. Hotel JW Marriot Medan, 17 Maret 2012.

44. Peserta Workshop “Diabetes Update for Excellent”. Hotel JW Marriot Medan, 17 Maret 2012.

45. Peserta Pelatihan Program Pengembangan Pendidikan Keprofesian Berkelanjutan FK USU Seminar “Management of Diagnostic Approach of Malaria”. Gedung Abdul Hakim FK USU, 3 Maret 2012.

46. Peserta Seminar dan Workshop on Managing Metabolic Syndrome “ Good Doctor for The Perfect Metabolism”. Santika Dyandra Hotel,

(6)

Terkini di Bidang Penyakit Dalam, Fokus Pada Infeksi. Medan, 6-8 Juni 2012.

48. Peserta Simposium Infection Update V Diagnostik dan Manajemen Terkini di Bidang Penyakit Dalam, Fokus Pada Infeksi . Medan, 6-8 Juni 2012.

49. Peserta dan Presenter Poster Kongres Nasional XV Perhimpunan Dokter Spesialis Penyakit Dalam Indonesia (KOPAPDI XV) Medan, 12 - 15 Desember 2012.

50. Peserta Workshop Terapi Insulin Kongres Nasional XV Perhimpunan Dokter Spesialis Penyakit Dalam Indonesia (KOPAPDI XV) Medan, 12 - 15 Desember 2012.

51. Peserta Simposium The 5th Endocrinology & Diabetes of Sumatera Region (FEDS-5) Theme : “The Endocrine-Metabolic Disease : Present and Future”. Hotel JW Marriot Medan, 22-23 Februari 2013. 52. Peserta Simposium Infection Update VI. Meningkatkan Kemampuan

Dalam Menghadapi Penyakit Infeksi Masa Kini, Hotel Danau Toba International.Medan, 07 September 2013.

53. Peserta Pertemuan Ilmiah Tahunan Ilmu Penyakit Dalam XIV & Gastroentero Hepatologi Update XI. Convention Center Hotel Tiara Medan. 12-14 September 2013.

54. Peserta Round Table Discussion Deme Thypoid,Aspek Klinis & Laboratorium. Hotel Santika Dyandra. Medan,20 January 2014. 55. Peserta Round Table Discussion.Aspek Klinis dan Laboratorium

Cystatin C untuk Deteksi Dini Penurunan Fungsi Ginjal. Grand Aston Hotel.Medan,22 Maret 2014.

56. .Peserta Medical Skill UP Grade (MEDSKUP) In Gastroenterology-Hepatology.Hotel Grand Aston City Hall. Medan, 05 April 2014.